iSERA Lifesciences Ltd (534920) — Board Meeting | 1 October 2026
The board approved the allotment of 1,61,82,800 equity shares at Rs 48.20 per share via share swap to promoters and non-promoter investors, increasing paid-up capital to Rs 2.46 crore, with all shares issued in dematerialized form.
About iSERA Lifesciences Ltd (534920)
Information Technology · IT - Software · Listed on BSE
📡 Get AI alerts when 534920 files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track 534920 — Free💡 Ask AI about this filing
📊 More 534920 filings
- 🟡 Board Meeting — 29 September 2026iSERA Lifesciences held its 34th Annual General Meeting on 29 September 2026 via video conference, w...
- Announcement — 28 September 2026iSERA Lifesciences announced that its trading window will close on October 1, 2026, and remain close...
- 🟡 Board Meeting — 5 September 2026The 34th Annual General Meeting of iSERA Lifesciences Limited (formerly Covidh Technologies) is sche...
- 🔴 Annual Report — 5 September 2026The 34th Annual General Meeting of iSERA Lifesciences Limited (formerly Covidh Technologies Limited)...
- 🟡 Board Meeting — 1 September 2026The board fixed September 29, 2026 as the date for the 34th Annual General Meeting to approve the au...
🔥 Also filed on 1 October 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts for your stocks — summarized by AI daily
Set up your AI Radar — pick stocks, get daily email summaries of new filings.
Set up AI Radar — FreeFree account · 2 AI queries/day